Archive for November 2022
Cannara Announces Normal Course Issuer Bid for Common Shares of the Corporation
Cannara Biotech Inc. announced that the company filed with the TSX Venture Exchange a Notice in respect of a normal course issuer bid to be transacted through the facilities of the TSX-V. Pursuant to the NCIB, Cannara may purchase up to 15,000,000 of its common shares representing approximately 1.7% of the total 877,481,321 common shares…
Read MoreForaco International secures US$55 m with Vale Canada including new contracts and negotiated extensions of other key drilling contracts in Canada for 2023 and beyond
Foraco International SA, a leading global provider of mineral and water drilling services, announced it has been awarded recently a series of major contracts with Vale Canada. Over the last few weeks, Foraco has won new contracts and successfully negotiated multiyear extensions to existing contracts with Vale Canada for the provision of exploration, definition drilling…
Read MoreViemed Announces New Senior Secured Credit Facilities
Viemed Healthcare, Inc., a national leader in respiratory care and technology-enabled home medical equipment services, announced that it has entered into new syndicated credit facilities. These consist of a five-year senior secured revolving credit facility of up to $30 million and a five-year delayed draw term loan facility of up to $30 million, which may…
Read MoreAlpha Cognition Announces Third Quarter 2022 Results and Provides Corporate Update
Alpha Cognition Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, reported financial results and provided a corporate update for the third quarter ended September 30, 2022. Alpha Cognition also announced that it has withdrawn the marketed public offering of units previously…
Read MoreCannara Biotech Inc. Reports Record Q4 and 2022 Fiscal Year Financial Results
Cannara Biotech Inc., a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., announced its fiscal fourth quarter and fiscal year 2022 financial and operating results for the three-month and full year periods ended August 31, 2022. The company recorded a record high…
Read MoreHamilton Thorne Reports Financial and Operational Results for the Quarter and Nine Months Ended September 30, 2022
Hamilton Thorne Ltd., a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, reported financial and operational results for the quarter and nine months ended September 30, 2022. Revenues were up 6% for the quarter and 14% for the nine months despite supply chain…
Read MoreAlpha Cognition Announces Marketed Offering
Alpha Cognition Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, announced it has commenced a marketed public offering of units for up to $10 million. The offering will be conducted on a best efforts agency basis pursuant to the terms and…
Read MoreThunderbird Entertainment Group Reports Fiscal 2023 Q1 Results
Thunderbird Entertainment Group Inc., a Bristol Investor Relations client, has announced its financial results for fiscal Q1 2023, which ended September 30, 2022, and provided a corporate update. Highlights included: Q1 2023 Revenue increased $8.6 million (25%) to $43.7 million compared to the prior year’s Q1, free cash flow of $4.4 million in the quarter…
Read MoreThailand’s biggest cinema operator Major Cineplex invest in live hologram technology, becoming world’s first cinema operator to purchase ARHT Media’s CAPSULE
ARHT Media Inc., a Bristol Investor Relations client and a global leader in the development, production and distribution of high-quality and low-latency hologram and digital content, announced that Thailand’s largest operator of movie theatres, MAJOR CINEPLEX, has purchased ARHT’s CAPSULE hologram display technology in a move that is set to revolutionize the cinema-going experience. MAJOR…
Read MoreCEMATRIX Announces Record 2022 Third Quarter Financial Results
CEMATRIX Corporation, a North American leading manufacturer and supplier of technologically advanced cellular concrete products, announced the release of its financial results for the quarter ended September 30, 2022. They announced $22.5 million in new contracts, which included the largest infrastructure project ever awarded in North America, a $20.3 million overpass backfill project in North…
Read MoreGreenbrook TMS Reports Third Quarter Operational and Financial Results
Greenbrook TMS Inc., a Bristol Investor Relations client, announced its third quarter 2022 operational and financial results. Some highlights included: Revenue for Q3 2022 increased by 58% to a record high of $20.8 million as compared to the third quarter of 2021. Quarterly treatment volumes in Q3 2022 increased by 74% to a record high…
Read MoreARHT Media Announces Record Q3 2022 Results: Achieves Over 90% Quarterly Revenue Growth
ARHT Media Inc., the global leader in the development, production and distribution of high-quality, low latency hologram and 3D interactive content, announced its financial results for the third quarter ended September 30, 2022. These included record Q3 2022 revenues of $2.02M vs $1.05M in Q3 2021, an increase of 92%, with significant momentum continuing into…
Read MoreViemed Healthcare Announces Third Quarter 2022 Financial Results
Viemed Healthcare, Inc. (a Bristol Investor Relations client) announced that it has reported its financial results for the three and nine months ended September 30, 2022. Operational highlights include that net revenues attributable to the company’s core business for the quarter ended September 30, 2022 were $35.8 million, a new company record, and an increase…
Read More